| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 07/24/2013 | EP2617413A2 Nano-vehicle derived from tumor tissue, and cancer vaccine using same |
| 07/24/2013 | EP2617293A1 Bitterness-masking ingredient and bitterness-masking method |
| 07/24/2013 | EP2616103A1 Asymmetric bifunctional silyl monomers and particles thereof as prodrugs and delivery vehicles for pharmaceutical, chemical and biological agents |
| 07/24/2013 | EP2616102A1 Prodrugs comprising an exendin linker conjugate |
| 07/24/2013 | EP2616101A1 Method for purifying pegylated erythropoietin |
| 07/24/2013 | EP2616091A1 Stabilization of immunoglobulins and other proteins through aqueous formulations with sodium chloride at weak acidic to neutral ph |
| 07/24/2013 | EP2616090A1 Stabilization of immunoglobulins through aqueous formulation with histidine at weak acidic to neutral ph |
| 07/24/2013 | EP2616078A1 Fulvestrant compositions and methods of use |
| 07/24/2013 | EP2616053A2 Pharmaceutical compositions of curcumin |
| 07/24/2013 | EP2616044A1 Pharmaceutical composition |
| 07/24/2013 | CN1853730B Modified cytokines for use in cancer therapy |
| 07/24/2013 | CN103221438A Process for the preparation of low-peroxide crosslinked vinyllactam polymer |
| 07/24/2013 | CN103221072A In vivo copper-free click chemistry for delivery of therapeutic and/or diagnostic agents |
| 07/24/2013 | CN103221070A Shear controlled release for stenotic lesions and thrombolytic therapies |
| 07/24/2013 | CN103221069A Alumina nanoparticle bioconjugates and methods of stimulating an immune response using said bioconjugates |
| 07/24/2013 | CN103221068A Anti-CD19 antibody having ADCC and CDC functions and improved glycosylation profile |
| 07/24/2013 | CN103221067A Phospholipid drug analogs |
| 07/24/2013 | CN103221066A Sustained-release pharmaceutical composition |
| 07/24/2013 | CN103221054A Novel polymer derivative of cytidine metabolism antagonist |
| 07/24/2013 | CN103221052A Fulvestrant compositions and methods of use |
| 07/24/2013 | CN103221042A Methods of treating bladder cancer |
| 07/24/2013 | CN103221037A Novel pharmaceutical compositions |
| 07/24/2013 | CN103221034A Nano-vehicle derived from tumor tissue, and cancer vaccine using same |
| 07/24/2013 | CN103221032A Pharmaceutical composition |
| 07/24/2013 | CN103215328A Transglutaminase mediated conjugation of peptides |
| 07/24/2013 | CN103214680A Preparation method and application method of novel amphipathic copolymerization network |
| 07/24/2013 | CN103214635A pH sensitive super-hydrophobic triblock copolymer as well as preparation method and application thereof |
| 07/24/2013 | CN103214625A Thermo-sensitive grafted hydrogel with function of resisting protein adsorption and preparation method thereof |
| 07/24/2013 | CN103214584A Fusion protein with double functions of inhibiting revascularization of tumor microenvironment and activating adaptive immune response, and gene and application thereof |
| 07/24/2013 | CN103214580A Anti Her2 immune cytokine and application thereof |
| 07/24/2013 | CN103214579A Animal fusion recombinant interferon |
| 07/24/2013 | CN103213967A Magnetic water-soluble carbon nano tube as well as preparation method and application thereof |
| 07/24/2013 | CN103212093A Magnetic nano-grade material with cell-targeting property, and biomedical application thereof |
| 07/24/2013 | CN103212090A Application of microvesicle containing TGF (transforming growth factor)-beta1 siRNA (small interfering Ribonucleic Acid) |
| 07/24/2013 | CN103212089A Preparation method and application of carbon nanomaterial-immunostimulatory sequence compound |
| 07/24/2013 | CN103212087A Antibiotic-chitosan covalent conjugate and preparation method and application thereof in preparation of anti-tumor medicines |
| 07/24/2013 | CN103212086A Podophyllotoxin nano prodrug with high drug loading capacity and preparation method and application thereof |
| 07/24/2013 | CN103212085A Molecules for targeting compounds to various selected organs or tissues |
| 07/24/2013 | CN103212084A IgG FC fragment for a drug carrier and method for the preparation thereof |
| 07/24/2013 | CN103212083A Method for preparing stable albumin nano-particles |
| 07/24/2013 | CN103212082A Novel load method of camptothecin anti-cancer drug |
| 07/24/2013 | CN103212081A Pharmaceutical composition as well as preparation method and application thereof |
| 07/24/2013 | CN103212080A Nano composition having cancer prevention and treatment effects and preparation method |
| 07/24/2013 | CN103212079A Oral medical composition for preventing and/or treating cold and application thereof |
| 07/24/2013 | CN103212075A Eye drop containing VEGF antagonist |
| 07/24/2013 | CN103212073A Coumarins and up-conversion rear earth nano-composite, and preparation method and application thereof |
| 07/24/2013 | CN103212072A An antigen associated with lung cancers and lymphomas |
| 07/24/2013 | CN103212068A Preparation method of chicken infectious bronchitis N-2-hydroxypropyl trimethyl ammonium chloride chitosan/carboxymethyl chitosan nano living vaccine |
| 07/24/2013 | CN103212065A Urease nano-reactor and preparation method thereof |
| 07/24/2013 | CN103212059A Composition containing antifungal drug and lactate buffering liquid |
| 07/24/2013 | CN103212058A Composition containing antifungal drug and lactate buffering agent |
| 07/24/2013 | CN103212056A Preparation based on gold, silver, gold-silver mixture and glutathione/chitosan, and application of preparation |
| 07/24/2013 | CN103212055A Drug composition of bortezomib and preparation method thereof |
| 07/24/2013 | CN103211927A Anti-aging composite tablet and preparation method thereof |
| 07/24/2013 | CN103211858A Si-Jun-Zi dropping pill preparation |
| 07/24/2013 | CN103211827A Compound amoxicillin oil suspension prescription and preparation method thereof |
| 07/24/2013 | CN103211826A Antiviral pharmaceutical composition as well as preparation method and application thereof |
| 07/24/2013 | CN103211825A Novel celecoxib composition and preparation process thereof |
| 07/24/2013 | CN103211818A Pharmaceutical composition for treating or preventing bacterial and mycoplasma diseases of livestock and use thereof |
| 07/24/2013 | CN103211813A Pharmaceutical composition containing clotrimazole |
| 07/24/2013 | CN103211811A Stable pharmaceutical composition |
| 07/24/2013 | CN103211800A Patch used for treating nausea and vomiting, and preparation method thereof |
| 07/24/2013 | CN103211798A Losartan potassium membrane controlled-release pellet capsule |
| 07/24/2013 | CN103211797A Verapamil hydrochloride film-controlled slow-release pellet capsule |
| 07/24/2013 | CN103211796A Salbutamol sulfate film-controlled slow-release pellet capsule |
| 07/24/2013 | CN103211795A Cefaclor film-controlled slow-release pellet capsule |
| 07/24/2013 | CN103211794A Quetiapine fumarate film-controlled slow-release pellet capsule |
| 07/24/2013 | CN103211793A Felodipine film-controlled slow-release pellet capsule |
| 07/24/2013 | CN103211792A Metoprolol fumarate film-controlled slow-release pellet capsule |
| 07/24/2013 | CN103211791A Venlafaxine hydrochloride film-controlled slow-release pellet capsule |
| 07/24/2013 | CN103211790A Tamsulosin hydrochloride film-controlled slow-release pellet capsule |
| 07/24/2013 | CN103211789A Ambroxol hydrochloride film-controlled slow-release pellet capsule |
| 07/24/2013 | CN103211788A Nifedipine film-controlled slow-release pellet capsule |
| 07/24/2013 | CN103211787A Glipizide film-controlled slow-release pellet capsule |
| 07/24/2013 | CN103211786A Choline fenofibrate film-controlled enteric slow-release pellet capsule |
| 07/24/2013 | CN103211785A Acipimox film-controlled slow-release pellet capsule |
| 07/24/2013 | CN103211784A Tolterodine tartrate film-controlled slow-release pellet capsule |
| 07/24/2013 | CN103211783A Dextromethorphan hydrobromide film-controlled slow-release pellet capsule |
| 07/24/2013 | CN103211782A Empty capsule suitable for being filled with traditional Chinese medicines |
| 07/24/2013 | CN103211781A Etoposide soft capsule |
| 07/24/2013 | CN103211774A Gabexate mesylate composition for injection and preparation method thereof |
| 07/24/2013 | CN103211772A Etoposide lyophilized powder for injection |
| 07/24/2013 | CN103211770A Igutimod slow release multielement composition and preparation method thereof |
| 07/24/2013 | CN103211769A Method of preparing a controlled release particle of soy isoflavone with biodegradable polymer using a supercritical fluid extraction of emulsion (SFEE) process |
| 07/24/2013 | CN103211768A Isosorbide mononitrate sustained-release pellet, and isosorbide mononitrate quick-release and sustained-release pellet capsule adopting it |
| 07/24/2013 | CN103211767A Preparation method of multifunctional eccentric mesoporous silicon dioxide core-shell nano particles |
| 07/24/2013 | CN103211764A Lipidosome combined with PYY analogue and preparation method thereof |
| 07/24/2013 | CN103211763A Florfenicol suspension emulsion injection for treating livestock respiratory diseases and preparation method thereof |
| 07/24/2013 | CN103211762A Novel diagnosis and treatment integrated hybridization micelle and preparation method thereof |
| 07/24/2013 | CN103211760A Clevidipine butyrate intralipid and preparation method thereof |
| 07/24/2013 | CN103211759A Puerarin nanocrystalline medical composition and preparation method thereof |
| 07/24/2013 | CN103211758A Liquid crystal nanoparticle transdermal agent and preparation method thereof |
| 07/24/2013 | CN103211757A Edaravone injection and preparation method thereof |
| 07/24/2013 | CN103211756A Long-acting doxycycline hydrochloride injection for animals and preparation method thereof |
| 07/24/2013 | CN103211753A Gel matrix |
| 07/24/2013 | CN103211752A Preparation and application of in-situ gel used for nystatin pH sensitive type vagina |
| 07/24/2013 | CN103211751A Medical composition containing vilazodone and preparation method thereof |
| 07/24/2013 | CN103211281A Preparation method of anti-oxidation water-in-oil microemulsion |
| 07/24/2013 | CN102793924B Medicinal premixing agent consisting of silicon dioxide and calcium hydrophosphate |
| 07/24/2013 | CN102772385B Stable tretinoin tablets and preparation method thereof |